Medicines Co. gets FDA approval of first patient-controlled patch for postoperative pain

The Medicines Company ($MDCO) scored two drug delivery feats on Friday. The FDA approved the company's Ionsys, making it the first patient-controlled patch for postoperative pain. In addition, the FDA approved the Medicine Company's Raplixa, the first spray powdered fibrin surgical sealant. More from FierceMedicalDevices

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.